Synchronous duodenal neuroendocrine neoplasm and congenital factor XIII deficiency: case report and review of the literature

被引:0
作者
Shen, Lei [1 ]
Kong, Lu [2 ]
Zhuo, Qi [3 ]
Rossi, Roberta Elisa [4 ]
Peixoto, Renata D'Alpino [5 ]
Tsoukalas, Nikolaos [6 ]
Zhang, Xiaomei [1 ]
Jin, Xinye [7 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Gastroenterol, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Patient Management, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Orthopaed, Beijing, Peoples R China
[4] Humanitas Clin & Res Ctr IRCCS, Gastroenterol & Endoscopy Unit, Milan, Italy
[5] Grp Oncoclin, Ctr Paulista Oncol, Sao Paulo, Brazil
[6] 401 Gen Mil Hosp Athens, Dept Oncol, Athens, Greece
[7] Chinese Peoples Liberat Army Gen Hosp, Hainan Hosp, Dept Endocrinol, Dept Nephrol,Acad Team Innovat Ctr, Sanya, Peoples R China
关键词
Duodenal neuroendocrine tumor (dNEN); bleeding disorders; factor XIII deficiency (FXIIID); pancreaticoduodenectomy (PD); case report; EPIDEMIOLOGY; TUMORS;
D O I
10.21037/atm-22-3628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Neuroendocrine neoplasms (NENs) are uncommon, with duodenal NENs (dNENs) being particularly rare in clinical practice. Congenital factor XIII deficiency (FXIIID) is also an extremely rare hematological disease in which poor wound healing may occur due to coagulopathy. The concurrent occurrence of these two rare diseases has not been reported before, which increases the difficulty of diagnosis and treatment. This is the first report of dNEN concomitant with Congenital FXIIID, which can present as a reference for clinicians who may encounter similar situations in the future. Case Description: We report a 33-year-old woman with bleeding diathesis since childhood who complained of digestive tract bleeding for 7 years. She was finally diagnosed as duodenal neuroendocrine neoplasm combined with congenital factor XIII deficiency. The patient underwent surgery, and pathological findings confirmed neuroendocrine tumor. After surgery she received cryoprecipitate and fresh frozen plasma (FFP) therapy. No tumor recurrence has been observed nor recurrence of digestive tract bleeding during the 2-year follow-up. Conclusions: Our report suggests when gastrointestinal bleeding is difficult to explain, more general examinations in addition to gastroscopy should be performed. In situations where digestive tract bleeding cannot be fully explained by a single disease, the possibility of concomitant disease, such as hematological disorders, should be considered to avoid the missed diagnosis of rare co-morbidities.
引用
收藏
页数:9
相关论文
共 21 条
[1]   Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort [J].
Bouttefroy, Severine ;
Meunier, Sandrine ;
Milien, Vanessa ;
Boucekine, Mohamed ;
Chamouni, Pierre ;
Desprez, Dominique ;
Harroche, Annie ;
Hochart, Audrey ;
Thiercelin-Legrand, Marie Francoise ;
Wibaut, Benedicte ;
Chambost, Herve ;
Rugeri, Lucia .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (02) :317-320
[2]   Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist [J].
Boyce, Malcolm ;
Thomsen, Liv .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (05) :550-559
[3]   Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? [J].
Das, Satya ;
Dasari, Arvind .
CURRENT ONCOLOGY REPORTS, 2021, 23 (04)
[4]   ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms [J].
Delle Fave, G. ;
O'Toole, D. ;
Sundin, A. ;
Taal, B. ;
Ferolla, P. ;
Ramage, J. K. ;
Ferone, D. ;
Ito, T. ;
Weber, W. ;
Zheng-Pei, Z. ;
De Herder, W. W. ;
Pascher, A. ;
Ruszniewski, P. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :119-124
[5]   Blood coagulation factor XIII and factor XIII deficiency [J].
Dorgalaleh, Akbar ;
Rashidpanah, Jamal .
BLOOD REVIEWS, 2016, 30 (06) :461-475
[6]   Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency [J].
Dorgalaleh, Akbar ;
Naderi, Majid ;
Shamsizadeh, Morteza .
ANNALS OF HEMATOLOGY, 2016, 95 (03) :451-455
[7]   A Rare Case of Factor XIII Deficiency in the Setting of Cancer Immunotherapy [J].
Farzam, Khashayar .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
[8]   Factor XIII and surgical bleeding [J].
Guilabert, Patricia ;
Asmis, Lars ;
Cortina, Vicente ;
Barret, Joan P. ;
Colomina, Maria J. .
MINERVA ANESTESIOLOGICA, 2022, 88 (03) :156-165
[9]   Hemorrhagic Acquired Factor XIII (13) Deficiency and Acquired Hemorrhaphilia 13 Revisited [J].
Ichinose, Akitada .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (04) :382-388
[10]   Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) [J].
Kaliszewski, Krzysztof ;
Ludwig, Maksymilian ;
Greniuk, Maria ;
Mikula, Agnieszka ;
Zagorski, Karol ;
Rudnicki, Jerzy .
CANCERS, 2022, 14 (08)